TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

Viagen

private
sign in to save

Viagen is a privately held company tracked for investment-relevant business and technology developments.

sentiment mix
bull 100%bear 0%neu 0%

funding rounds

private markets
awaiting round data

This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.

signal summary

latest high-conviction thesis
Colossal acquired Viagen for 80% cloning efficiency vs 2% industry standard▾

Vertical integration drove Colossal to acquire Viagen, the only US animal cloning company with 80% efficiency (vs 2% typical), securing the cloning layer for endangered species production and de-extinction pipeline.

ben lammT2Sourcery VC2026-08-20
confidence 78 / 100impact High
key themes
  • Gene & Cell Therapy100%
  • Conservation Technology100%
  • Vertical Integration100%
  • Life Sciences & Drug Development100%
  • Agriculture Technology100%

bull thesis · 3

89 / 100
  • •Colossal acquires Viagen for 80% cloning efficiency vs 2% industry standard
  • •Colossal acquired Viagen for 80% cloning efficiency vs 2% industry standard
  • •Colossal acquires Viagen for 80% cloning efficiency vs 2% industry standard to vertically integrate

bear thesis · 0

—
  • — none —

mentions · 3

Sourcery VC$12B De-Extinction Company Colossal Biosciences Spun Out $3.8B Astromech3 mentions · 3▲ 0▼ 0○ · last month
0:007:0015:0022:0030:00